Cencora, Inc., formerly AmerisourceBergen, is a leading American pharmaceutical wholesale and distribution company. Formed in 2001 from the merger of Bergen Brunswig and AmeriSource, Cencora distributes a wide range of pharmaceuticals and healthcare products across the US, handling about 20% of the market. In fiscal year 2023, Cencora reported annual revenue of USD 262.2 billion, a 9.9% increase from the previous year. In the first quarter of fiscal year 2024, the company achieved USD 72.3 billion in revenue, a 15% year-over-year increase, while the second quarter saw USD 68.4 billion, up 7.8% from the prior year.